The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
valganciclovir · VALGANCICLOVIR HYDROCHLORIDE 50 mg/mL · For Solution · Oral · airis PHARMA PVT LTD
NDC 71151-0003-01 · 100 mL in 1 BOTTLE, DISPENSING · ANDA · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| airis PHARMA PVT LTD | VALGANCICLOVIR HYDROCHLORIDE 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Granules Pharmaceuticals Inc. | VALGANCICLOVIR 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | VALGANCICLOVIR 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Valganciclovir — NDC 71151-0003-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71151000301.
Free to cite with attribution — see how the data is put together.